Demographic Data |
Relation to Proband |
proband |
Age at Sampling |
3 YR |
Sex |
Female |
Age of Onset(If not a control) |
8 MO |
Age at Diagnosis(If not a control) |
3 YR |
Hispanic or Latino/Not Hispanic or Latino |
Not Hispanic/Latino |
Racial Category |
White |
Country |
USA |
|
Data Elements |
Clinical Element Type: General NIGMS Catalog Remarks |
(Baseline) |
Mutation Information |
Gene, variant, consequence, and exon number: |
WHOLE EXOME TRIO SEQUENCING REVEALED A DE NOVO MUTATION IN THE SYNGAP1 GENE (NM_006772.2): C.3718 C>T IN EXON 17 (P.R1240X); CHR6:33,414,461-33,459,293 44,833 BP; GRCH38/HG 38 |
Zygosity: |
Heterozygous |
Age of Symptom Onset and Age at Diagnosis |
Age of Symptom Onset: |
8 MONTHS |
Age at Diagnosis: |
3 YEARS |
In Utero History Information |
|
|
Birth History Information |
|
|
Dysmorphic Features |
|
Strabismus
|
Additional Information: |
STRABISMUS IN BOTH EYES CORRECTED THROUGH SURGERY |
Neurological Symptoms |
|
Seizures
|
Additional Information: |
LOW MUSCLE TONE; SUBCLINICAL AND MYOCLONIC SEIZURES; STEREOTYPY |
Optical and Audiological Symptoms |
|
|
Additional Information: |
EAR TUBES |
Musculoskeletal Symptoms |
|
|
Developmental Milestones |
|
Delayed speech and language development Global developmental delay Delayed fine motor skills Delayed gross motor skills
|
Additional Information: |
APRAXIA; TROUBLE SPEAKING |
Gastrointestinal Symptoms |
|
|
Genitourinary Symptoms |
|
|
Respiratory and Cardiovascular Symptoms |
|
|
Cognitive and Behavioral Symptoms |
|
|
Additional Information: |
INTELLECTUAL DISABILITY |
Additional Information |
Testing Performed |
Treatments and Assistive Devices |
|
Occupational therapy Physical therapy Speech therapy
|
Medications |
|
KEPPRA |
Family History |
|
BOTH PARENTS (NOT IN REPOSITORY) ARE NEGATIVE FOR THE PATHOGENIC VARIANT IN SYNGAP1; THE POSSIBILITY OF GERMLINE MOSAICISM SHOULD BE CONSIDERED. |
Remarks |
See Phenotypic Data tab. Same subject as GM27957 (iPSC). |